Pulmonary vasculitis due to infection with Mycobacterium goodii: A case report

•This is the first reported case of vasculitis caused by Mycobacterium goodii.•Treatment consisted of antimycobacterial and anti-inflammatory drugs.•PET-CT served as the disease-monitoring tool in this special vasculitis. A 57-year-old Caucasian woman suffered from dyspnea on exertion. One year foll...

Full description

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases 2021-03, Vol.104, p.178-180
Main Authors: Pfeuffer-Jovic, Elena, Heyckendorf, Jan, Reischl, Udo, Bohle, Rainer M., Bley, Thorsten, Buck, Andreas, Wilkens, Heinrike, Schäfers, Hans-Joachim, Langen, Heinz-Jakob, Held, Matthias
Format: Article
Language:English
Subjects:
Arteritis
Female
Gram-Positive Bacterial Infections - diagnostic imaging
Gram-Positive Bacterial Infections - drug therapy
Gram-Positive Bacterial Infections - microbiology
Humans
Lung Diseases - diagnostic imaging
Lung Diseases - drug therapy
Lung Diseases - microbiology
Middle Aged
Mycobacteriaceae - genetics
Mycobacteriaceae - isolation & purification
Mycobacterium goodii
Nontuberculous Mycobacteria
Positron Emission Tomography Computed Tomography
Vasculitis
Vasculitis - diagnostic imaging
Vasculitis - drug therapy
Vasculitis - microbiology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•This is the first reported case of vasculitis caused by Mycobacterium goodii.•Treatment consisted of antimycobacterial and anti-inflammatory drugs.•PET-CT served as the disease-monitoring tool in this special vasculitis. A 57-year-old Caucasian woman suffered from dyspnea on exertion. One year following a supposed pulmonary embolism event, a chronic thromboembolic vasculopathy was diagnosed and a pulmonary thromboendarterectomy was performed. However, a granulomatous pulmonary arterial vasculitis was identified upon examination. DNA of Mycobacterium goodii was detected as the most likely causative agent. Anti-inflammatory and anti-mycobacterial therapy was initiated for more than 12 months. Regular PET-CT scans revealed improvement under therapy. The last PET-CT did not show any tracer uptake following 10 months of therapy.
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2020.12.074